Kidney / Liver Care

What Are Kidney / Liver Care?

Chronic kidney disease (CKD) affects approximately 850 million people globally and is a leading cause of cardiovascular death. Liver disease — including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and cirrhosis — accounts for over 2 million deaths annually. AmozonPill stocks 44 generic kidney and liver care medications covering hepatoprotective agents, phosphate binders, renal anaemia treatments, and hepatic encephalopathy agents — sourced from FDA-inspected, WHO-GMP manufacturers at up to 95% below brand-name prices. 

 Drug Classes Available

• Hepatoprotective & Liver Agents: Ursodeoxycholic Acid (UDCA), Silymarin (Milk Thistle), N-Acetylcysteine — UDCA for primary biliary cholangitis and NASH; Silymarin hepatoprotective in alcoholic liver disease; NAC for paracetamol hepatotoxicity and NAFLD. 
• Hepatic Encephalopathy: Lactulose, Rifaximin — Lactulose reduces ammonia absorption from the gut; Rifaximin (gut-selective antibiotic) reduces ammonia-producing gut bacteria. Together the gold-standard prevention of hepatic encephalopathy in cirrhosis. 
• Renal Phosphate Binders: Sevelamer, Calcium Carbonate, Lanthanum Carbonate — bind dietary phosphate in the gut, reducing hyperphosphataemia in CKD patients on dialysis. Sevelamer is preferred as it avoids calcium load. 
• Calcimimetics: Cinacalcet — reduces parathyroid hormone (PTH) levels in secondary hyperparathyroidism in dialysis patients. Reduces hypercalcaemia of malignancy. 
• Renal Anaemia Agents: Ferrous Sulphate, Ferric Carboxymaltose, Folic Acid, B12 — iron and vitamin supplementation essential for renal anaemia management alongside erythropoietin (ESA) therapy. 

 Why Buy Generic?

• Generic UDCA from $24 vs $90+ for Ursodiol brand 
• Generic Rifaximin from $32 vs $250+ for Xifaxan brand 
• Generic Cinacalcet from $28 vs $180+ for Sensipar brand 
• FDA-inspected, WHO-GMP-certified manufacturers 
• Free shipping on orders over $199 

How to Choose the Right Product

For primary biliary cholangitis (PBC): UDCA 13–15 mg/kg/day in divided doses is the only approved first-line pharmacotherapy. For alcoholic or drug-induced liver disease: Silymarin 140 mg three times daily and NAC have hepatoprotective evidence. For hepatic encephalopathy prophylaxis: Lactulose titrated to 2–3 soft stools daily; add Rifaximin 550 mg twice daily for recurrent episodes. For CKD hyperphosphataemia: Sevelamer with meals. All kidney and liver care medications should be supervised by a nephrologist or hepatologist. 

Frequently Asked Questions

What is UDCA and what conditions does it treat? 

Ursodeoxycholic Acid (UDCA) is a naturally occurring bile acid that reduces cholesterol saturation in bile and has hepatoprotective and anti-cholestatic properties. It is the only pharmacological treatment approved for primary biliary cholangitis (PBC) and is also used for cholesterol gallstone dissolution and NAFLD. 

How does Lactulose work in liver disease? 

In cirrhosis, impaired liver detoxification allows ammonia to accumulate in the blood, causing hepatic encephalopathy (confusion, cognitive impairment). Lactulose acidifies the colon, trapping ammonia as ammonium ions and promoting its excretion in stool. The target is 2–3 soft stools daily. 

What is Rifaximin used for in liver disease? 

Rifaximin is a gut-selective, minimally absorbed antibiotic that reduces ammonia-producing gut bacteria without systemic antibiotic exposure. Adding Rifaximin 550 mg twice daily to Lactulose reduces recurrent hepatic encephalopathy episodes by 58% vs Lactulose alone. 

Why do CKD patients need phosphate binders? 

In CKD, impaired renal phosphate excretion causes hyperphosphataemia, which drives secondary hyperparathyroidism, vascular calcification, and cardiovascular mortality. Phosphate binders (Sevelamer, Calcium Carbonate) reduce GI phosphate absorption, lowering serum phosphate and PTH. 

Can N-Acetylcysteine help liver disease? 

NAC is the established antidote for paracetamol (acetaminophen) hepatotoxicity — it replenishes glutathione, enabling detoxification of the toxic metabolite NAPQI. It is also used as a hepatoprotective agent in non-alcoholic fatty liver disease and as a mucolytic. 

What lifestyle changes protect kidney function in CKD? 

Key measures: blood pressure control below 130/80 mmHg (ACE inhibitor or ARB preferred), blood glucose optimisation in diabetic CKD, low-protein diet (0.6–0.8 g/kg/day), dietary phosphate restriction, smoking cessation, weight management, and avoidance of nephrotoxic medications (NSAIDs, contrast agents).